Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Moderna Inc has a consensus price target of $66.64 based on the ratings of 27 analysts. The high is $150 issued by Cowen & Co. on January 25, 2023. The low is $26 issued by JP Morgan on May 22, 2025. The 3 most-recent analyst ratings were released by JP Morgan, UBS, and Barclays on May 22, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $45.33 between JP Morgan, UBS, and Barclays, there's an implied 71.52% upside for Moderna Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/22/2025 | Buy Now | -1.63% | JP Morgan | Jessica Fye63% | $33 → $26 | Maintains | Underweight | Get Alert |
05/02/2025 | Buy Now | 164.85% | UBS | Eliana Merle43% | $78 → $70 | Maintains | Buy | Get Alert |
05/02/2025 | Buy Now | 51.34% | Barclays | Gena Wang50% | $45 → $40 | Maintains | Equal-Weight | Get Alert |
05/02/2025 | Buy Now | 5.94% | RBC Capital | Luca Issi42% | $32 → $28 | Maintains | Sector Perform | Get Alert |
05/02/2025 | Buy Now | 21.07% | Evercore ISI Group | Cory Kasimov68% | $50 → $32 | Maintains | In-Line | Get Alert |
04/09/2025 | Buy Now | 21.07% | Morgan Stanley | Matthew Harrison61% | $39 → $32 | Maintains | Equal-Weight | Get Alert |
03/21/2025 | Buy Now | 24.86% | JP Morgan | Jessica Fye63% | $40 → $33 | Maintains | Underweight | Get Alert |
03/13/2025 | Buy Now | 51.34% | Citigroup | Geoff Meacham61% | → $40 | Initiates | → Neutral | Get Alert |
02/19/2025 | Buy Now | 195.12% | UBS | Eliana Merle43% | $96 → $78 | Maintains | Buy | Get Alert |
02/18/2025 | Buy Now | 51.34% | RBC Capital | Luca Issi42% | $40 → $40 | Reiterates | Sector Perform → Sector Perform | Get Alert |
02/18/2025 | Buy Now | 70.26% | Barclays | Gena Wang50% | $111 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
02/11/2025 | Buy Now | 28.64% | B of A Securities | Tim Anderson59% | $41 → $34 | Maintains | Underperform | Get Alert |
01/29/2025 | Buy Now | 92.96% | Goldman Sachs | Salveen Richter53% | $99 → $51 | Downgrade | Buy → Neutral | Get Alert |
01/28/2025 | Buy Now | 274.57% | Goldman Sachs | Salveen Richter53% | $112 → $99 | Maintains | Buy | Get Alert |
01/27/2025 | Buy Now | 89.18% | Evercore ISI Group | Cory Kasimov68% | $60 → $50 | Maintains | In-Line | Get Alert |
01/15/2025 | Buy Now | 43.78% | Morgan Stanley | Matthew Harrison61% | $70 → $38 | Maintains | Equal-Weight | Get Alert |
01/08/2025 | Buy Now | 263.22% | UBS | Eliana Merle43% | $108 → $96 | Maintains | Buy | Get Alert |
12/18/2024 | Buy Now | — | Argus Research | John Eade75% | — | Downgrade | Buy → Hold | Get Alert |
12/10/2024 | Buy Now | 55.13% | B of A Securities | Tim Anderson59% | → $41 | Reinstates | → Underperform | Get Alert |
11/26/2024 | Buy Now | 70.26% | JP Morgan | Jessica Fye63% | $59 → $45 | Maintains | Underweight | Get Alert |
11/18/2024 | Buy Now | 161.07% | Piper Sandler | Edward Tenthoff50% | $115 → $69 | Reiterates | Overweight → Overweight | Get Alert |
11/18/2024 | Buy Now | 119.45% | HSBC | Yifeng Liu34% | → $58 | Upgrade | Hold → Buy | Get Alert |
11/15/2024 | Buy Now | 51.34% | Wolfe Research | Alexandria Hammond41% | → $40 | Initiates | → Underperform | Get Alert |
11/08/2024 | Buy Now | 319.98% | Barclays | Gena Wang50% | $125 → $111 | Maintains | Overweight | Get Alert |
11/08/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
11/04/2024 | Buy Now | 123.23% | JP Morgan | Jessica Fye63% | $70 → $59 | Maintains | Underweight | Get Alert |
10/24/2024 | Buy Now | 308.63% | UBS | Eliana Merle43% | $140 → $108 | Maintains | Buy | Get Alert |
10/17/2024 | Buy Now | 108.1% | Bernstein | Courtney Breen1% | → $55 | Initiates | → Market Perform | Get Alert |
10/15/2024 | Buy Now | 108.1% | Jefferies | Michael Yee55% | $65 → $55 | Maintains | Hold | Get Alert |
09/19/2024 | Buy Now | 183.77% | RBC Capital | Luca Issi42% | $75 → $75 | Reiterates | Sector Perform → Sector Perform | Get Alert |
09/16/2024 | Buy Now | 425.92% | Goldman Sachs | Salveen Richter53% | $178 → $139 | Maintains | Buy | Get Alert |
09/16/2024 | Buy Now | 372.95% | Barclays | Gena Wang50% | $155 → $125 | Maintains | Overweight | Get Alert |
09/13/2024 | Buy Now | 316.19% | B of A Securities | Geoff Meacham61% | $130 → $110 | Maintains | Neutral | Get Alert |
09/13/2024 | Buy Now | 335.11% | Piper Sandler | Edward Tenthoff50% | $157 → $115 | Maintains | Overweight | Get Alert |
09/13/2024 | Buy Now | 127.01% | TD Cowen | Tyler Van Buren45% | $70 → $60 | Maintains | Hold | Get Alert |
09/13/2024 | Buy Now | 183.77% | RBC Capital | Luca Issi42% | $90 → $75 | Maintains | Sector Perform | Get Alert |
09/13/2024 | Buy Now | 164.85% | JP Morgan | Jessica Fye63% | $88 → $70 | Downgrade | Neutral → Underweight | Get Alert |
09/13/2024 | Buy Now | 145.93% | Jefferies | Michael Yee55% | $120 → $65 | Downgrade | Buy → Hold | Get Alert |
09/13/2024 | Buy Now | — | Oppenheimer | Hartaj Singh45% | — | Downgrade | Outperform → Perform | Get Alert |
09/13/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
08/28/2024 | Buy Now | 210.25% | HSBC | Yifeng Liu34% | → $82 | Upgrade | Reduce → Hold | Get Alert |
08/15/2024 | Buy Now | 232.95% | JP Morgan | Jessica Fye63% | $96 → $88 | Maintains | Neutral | Get Alert |
08/06/2024 | Buy Now | 202.69% | Deutsche Bank | Emmanuel Papadakis47% | $85 → $80 | Upgrade | Sell → Hold | Get Alert |
08/05/2024 | Buy Now | 240.52% | RBC Capital | Luca Issi42% | $125 → $90 | Downgrade | Outperform → Sector Perform | Get Alert |
08/02/2024 | Buy Now | 372.95% | RBC Capital | Luca Issi42% | $160 → $125 | Maintains | Outperform | Get Alert |
08/02/2024 | Buy Now | 573.48% | Goldman Sachs | Salveen Richter53% | $204 → $178 | Maintains | Buy | Get Alert |
08/02/2024 | Buy Now | 486.45% | Barclays | Gena Wang50% | $168 → $155 | Maintains | Overweight | Get Alert |
08/02/2024 | Buy Now | 494.02% | Piper Sandler | Edward Tenthoff50% | $214 → $157 | Reiterates | Overweight → Overweight | Get Alert |
08/01/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
06/28/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
06/27/2024 | Buy Now | 709.69% | Piper Sandler | Edward Tenthoff50% | $214 → $214 | Reiterates | Overweight → Overweight | Get Alert |
06/27/2024 | Buy Now | 354.03% | Evercore ISI Group | Cory Kasimov68% | $120 → $120 | Maintains | In-Line | Get Alert |
06/12/2024 | Buy Now | 263.22% | JP Morgan | Jessica Fye63% | $85 → $96 | Maintains | Neutral | Get Alert |
06/12/2024 | Buy Now | 577.26% | Oppenheimer | Hartaj Singh45% | $163 → $179 | Maintains | Outperform | Get Alert |
06/03/2024 | Buy Now | 505.37% | RBC Capital | Luca Issi42% | $135 → $160 | Maintains | Outperform | Get Alert |
06/03/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
05/14/2024 | Buy Now | 354.03% | Evercore ISI Group | Cory Kasimov68% | → $120 | Initiates | → In-Line | Get Alert |
05/07/2024 | Buy Now | 471.32% | UBS | Eliana Merle43% | $143 → $151 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 301.06% | Canaccord Genuity | Bill Maughan19% | $91 → $106 | Maintains | Hold | Get Alert |
05/03/2024 | Buy Now | 410.78% | RBC Capital | Luca Issi42% | $125 → $135 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 516.72% | Oppenheimer | Hartaj Singh45% | $142 → $163 | Maintains | Outperform | Get Alert |
05/02/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
04/11/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
04/09/2024 | Buy Now | 372.95% | Jefferies | Michael Yee55% | → $125 | Reiterates | Buy → Buy | Get Alert |
03/28/2024 | Buy Now | 372.95% | RBC Capital | Luca Issi42% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
03/28/2024 | Buy Now | — | Needham | Joseph Stringer55% | — | Reiterates | → Hold | Get Alert |
03/15/2024 | Buy Now | 221.6% | JP Morgan | Jessica Fye63% | $90 → $85 | Maintains | Neutral | Get Alert |
02/26/2024 | Buy Now | 225.39% | HSBC | Yifeng Liu34% | $75 → $86 | Downgrade | Hold → Reduce | Get Alert |
02/23/2024 | Buy Now | 372.95% | RBC Capital | Luca Issi42% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
02/23/2024 | Buy Now | 244.31% | Canaccord Genuity | Bill Maughan19% | $82 → $91 | Maintains | Hold | Get Alert |
01/12/2024 | Buy Now | 372.95% | RBC Capital | Luca Issi42% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
01/02/2024 | Buy Now | 437.27% | Oppenheimer | Hartaj Singh45% | → $142 | Upgrade | Perform → Outperform | Get Alert |
12/01/2023 | Buy Now | 240.52% | JP Morgan | Jessica Fye63% | $93 → $90 | Maintains | Neutral | Get Alert |
11/29/2023 | Buy Now | 210.25% | Canaccord Genuity | Bill Maughan19% | → $82 | Initiates | → Hold | Get Alert |
11/03/2023 | Buy Now | 372.95% | RBC Capital | Luca Issi42% | $180 → $125 | Maintains | Outperform | Get Alert |
11/03/2023 | Buy Now | 774.01% | Goldman Sachs | Salveen Richter53% | $269 → $231 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 161.07% | HSBC | Yifeng Liu34% | $89 → $69 | Upgrade | Reduce → Hold | Get Alert |
11/02/2023 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | — | Downgrade | Hold → Sell | Get Alert |
09/13/2023 | Buy Now | 429.7% | Argus Research | Jasper Hellweg68% | $160 → $140 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 365.38% | Morgan Stanley | Matthew Harrison61% | $128 → $123 | Maintains | Equal-Weight | Get Alert |
08/04/2023 | Buy Now | 467.54% | B of A Securities | Geoff Meacham61% | $175 → $150 | Maintains | Neutral | Get Alert |
08/04/2023 | Buy Now | 618.88% | RBC Capital | Luca Issi42% | $200 → $190 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 372.95% | TD Cowen | Tyler Van Buren45% | $145 → $125 | Downgrade | Outperform → Market Perform | Get Alert |
08/03/2023 | Buy Now | 372.95% | Deutsche Bank | Emmanuel Papadakis47% | $200 → $125 | Downgrade | Buy → Hold | Get Alert |
07/24/2023 | Buy Now | 524.29% | TD Cowen | Tyler Van Buren45% | $175 → $165 | Maintains | Outperform | Get Alert |
07/24/2023 | Buy Now | — | William Blair | Myles Minter38% | — | Initiates | → Market Perform | Get Alert |
07/14/2023 | Buy Now | 267.01% | HSBC | Rajesh Kumar62% | → $97 | Initiates | → Reduce | Get Alert |
07/11/2023 | Buy Now | 384.3% | Morgan Stanley | Matthew Harrison61% | $153 → $128 | Maintains | Equal-Weight | Get Alert |
06/26/2023 | Buy Now | 622.66% | UBS | Eliana Merle43% | $221 → $191 | Upgrade | Neutral → Buy | Get Alert |
05/05/2023 | Buy Now | 630.23% | Morgan Stanley | Matthew Harrison61% | $185 → $193 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | — | Guggenheim | Evan Wang8% | — | Initiates | → Neutral | Get Alert |
04/12/2023 | Buy Now | 429.7% | JP Morgan | Jessica Fye63% | $145 → $140 | Maintains | Neutral | Get Alert |
04/10/2023 | Buy Now | 448.62% | JP Morgan | Jessica Fye63% | $127 → $145 | Maintains | Neutral | Get Alert |
03/13/2023 | Buy Now | 581.04% | TD Cowen | Tyler Van Buren45% | $150 → $180 | Upgrade | Market Perform → Outperform | Get Alert |
03/02/2023 | Buy Now | 656.72% | RBC Capital | Luca Issi42% | → $200 | Initiates | → Outperform | Get Alert |
02/28/2023 | Buy Now | 656.72% | Deutsche Bank | Emmanuel Papadakis47% | $225 → $200 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 251.87% | SVB Leerink | Mani Foroohar47% | $111 → $93 | Downgrade | Market Perform → Underperform | Get Alert |
02/08/2023 | Buy Now | 422.13% | JP Morgan | Jessica Fye63% | $132 → $138 | Maintains | Neutral | Get Alert |
01/25/2023 | Buy Now | 467.54% | Cowen & Co. | Tyler Van Buren45% | $130 → $150 | Maintains | Market Perform | Get Alert |
01/24/2023 | Buy Now | 675.63% | Morgan Stanley | Matthew Harrison61% | $209 → $205 | Maintains | Equal-Weight | Get Alert |
The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on May 22, 2025. The analyst firm set a price target for $26.00 expecting MRNA to fall to within 12 months (a possible -1.63% downside). 56 analyst firms have reported ratings in the last year.
The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their underweight rating.
The last upgrade for Moderna Inc happened on November 18, 2024 when HSBC raised their price target to $58. HSBC previously had a hold for Moderna Inc.
The last downgrade for Moderna Inc happened on February 18, 2025 when Barclays changed their price target from $111 to $45 for Moderna Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $33.00 to $26.00. The current price Moderna (MRNA) is trading at is $26.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.